Recent Publications

Division Publications

---

Laurie SJ, Liu D, Wagener ME, Terhorst C, Ford ML. 2B4-mediated inhibition of proliferation and glycolytic capacity attenuate CD8+ T Cell responses during transplantation. Cutting Edge. J Immunol 2017.

Rogers GL, Shirley JL, Zolotukhin I, Kumar SRP, Sherman A, Perrin GQ, Hoffman BE, Srivastava A, Basner-Tschakarjan E, Wallet MA, Terhorst C, Herzog RW. 2017 Plasmacytoid and conventional dendritic cells cooperate in cross-priming AAV capsid-specific CD8+T cells. Blood 2017; 129:3184-95.

Wang N, Keszei M, Halibozek P, Engel P, Terhorst C. Slamf6 negatively regulates autoimmunity. Clinical Immunol 2016; 173:19-26.

Yigit B, Wang N, Chen S, Chiorazzi N, Terhorst C. Inhibition of reactive oxygen species (ROS) limits tumor expansion in a mouse model of CLL. Leukemia 2017.

Zhou J, O'Keeffe M, Liao G, Zhao F, Terhorst C & Bing Xu. 2016. Design and synthesis of nanofibers of self-assembled de novo Glycoconjugates towards mucosal lining restoration and anti-inflammatory drug delivery. Tetrahedron 2016; 72:6078-83.

Bologna C, Buonincontri R, Serra S, Vaisitti T, Audrito V, Brusa D, Pagnani A, Coscia M, D’Arena G, Mereu E, Piva R, Furman RR, Rossi D, Gaidano G, Terhorst C, Deaglio S. SLAMF1 regulation of chemotaxis and autophagy determines CLL patient response. J Clin Invest 2016; 126:181-94.

Chaudhary A, Leite M, Kulasekara BR, Altura MA, Ogahara C, Weiss E, Fu W, Blanc MP, O’Keeffe M, Terhorst C, Akey JM, Miller SI. Human diversity in a cell surface receptor that inhibits autophagy. Curr Biol 2016; 26:1791-801.

Cuenca M, Romero X, Sintes J, Terhorst C, Engel P. Targeting of Ly9 (CD229) disrupts marginal zone and B1 B cell homeostasis and antibody responses. J Immunol 2016; 196:726-37.                                                                                                                          
van Driel BJ, Liao G, Engel P, Terhorst C. Responses to microbial challenges by SLAMF receptors. Front Immunol 2016; 7:4.

Yigit B, Halibozek PJ, Chen SS, O’Keeffe MS, Arnason J, Avigan D, Gattei V, Bhan A, Cen O, Longnecker R, Chiorazzi N, Wang N, Engel P, Terhorst C. A combination of an anti-SLAMF6 antibody and ibrutinib efficiently abrogates expansion of chronic lymphocytic leukemia cells. Oncotarget 2016; 7:26346-60.

Biswas M, Sarkar D, Nayak S, Kumar S, Rogers GL, Markusic DM, Liao G, Terhorst C, Herzog RW. Synergy between rapamycin and FLT3 ligand enhances plasmacytoid dendritic cell-dependent induction of CD4+CD25+FoxP3+ Treg. Blood 2015; 125(19):2937-47. 

O’Keeffe M, Song JH, Gongxian Liao, DeCalisto J, Mora HR, Halibozek P, Bhan AK, Wang N, Reinecker H-C, Terhorst C . Slamf4 on the surface of intra-epithelial T lymphocytes controls homeostasis of dendritic cells in the small intestine. Gastroenterology 2015; 148(5):991-1001.

Thiele M, Kerschbaumer RJ, Tam FWK, Völkel D, Douillard P, Schinagl A, Kühnel H, Smith J, McDaid JP, Bhangal G, Yu M-C, Pusey CD, Cook HT, Kovarik J, Magelky E, Rieger M, Mudde CM, Ehrlich H, Tilg H, Terhorst C, Scheiflinger F. Selective targeting of a disease-related conformational isoform of macrophage migration inhibitory factor ameliorates inflammatory conditions. J Immunol 2015; 195 (5):2343-2352.

Wang G, van Driel BJ, Liao G, O’Keeffe MS, Halibozek PJ, Yigit B, Azcutia V, Luscinskas FW, Wang N, Terhorst C. Migration of myeloid cells during inflammation is differentially regulated by the cell surface receptors Slamf1 and Slamf8. PLoS One 2015; 23;10(3):e0121968.

Wang N, Yigit B, Halibozek P, DeCalisto J, Terhorst C. A combination of Slamf1, Slamf5 and Slamf6 signaling negatively regulates humoral immune responses. Frontiers in Immunology 2015; 6:158